Updated from 2:49 p.m. EDT April 8

Widely held health care-related stocks were mostly up Wednesday amid a rally in the broader market.

Eli Lilly ( LLY) shares rose 1.2% to $32.34 Wednesday afternoon after the company, along with Daiichi Sankyo, launched blood-thinner Efient in the U.K. Efient, or prasugrel, was approved in February by European officials to help prevent blood clots in heart patients with stents. It will compete with Plavix, sold by Bristol-Myers Squibb ( BMY) and Sanofi-Aventis ( SNY). Bristol shares rose 1.6% to $20.41. Sanofi-Aventis shares rose 0.5% to $27.71.

Also on the plus side was Merck ( MRK), shares of which rose 1.4% to $26.76.

Among the day's losers:

GlaxoSmithKline ( GSK) shares fell 0.3% to $30.06.

Pfizer ( PFE) shares fell 0.4% to $13.48 in choppy trading.

Procter & Gamble ( PG) shares fell 0.7% to $48.47 after the company said it was cutting about 90 jobs at a plant in Puerto Rico that makes Olay skin care products and Vicks cold medicine.

If you liked this article you might like

Health Stock Winners and Losers: Bristol, Glaxo

Health Stock Winners and Losers: Bristol, Glaxo

Health Winners and Losers: AstraZeneca

Health Winners and Losers: AstraZeneca

AT&T Near Deal to Buy Alltel Assets: Report

AT&T Near Deal to Buy Alltel Assets: Report

Chips Pummeled; Nvidia Swings to Loss

Chips Pummeled; Nvidia Swings to Loss

Google's Schmidt: Why Would I Leave Apple's Board?

Google's Schmidt: Why Would I Leave Apple's Board?